Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Joshua Cohen$130.6M
Market Cap • 25/07/20242014
(há 10 anos)
2022
(2 years ago)
NASDAQ
Listagem
Cambridge
Sede • Massachusetts262
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
AMLXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.